These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 31661127)

  • 1. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
    Li J; Chen N; Gong X
    Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma.
    Liu L; Chen J; Ye F; Yan Y; Wang Y; Wu J
    Technol Cancer Res Treat; 2024; 23():15330338241276895. PubMed ID: 39155614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Amino Acid-Related Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Wang S; Huang H; Hu X; Xiao M; Yang K; Bu H; Jiang Y; Huang Z
    Cancer Rep (Hoboken); 2024 Jul; 7(7):e2131. PubMed ID: 39041652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.
    Wang X; Yu T; Liao X; Yang C; Han C; Zhu G; Huang K; Yu L; Qin W; Su H; Liu X; Peng T
    Cancer Med; 2018 Apr; 7(4):966-980. PubMed ID: 29479826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of RAC1-related immune and prognostic subtypes of hepatocellular carcinoma.
    Wang W; Xia H; Feng P; Dai B
    J Gene Med; 2024 Jul; 26(7):e3719. PubMed ID: 38979878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive evaluation of genes related to basement membrane in hepatocellular carcinoma.
    Wu G; Li F; Guo D; Xi K; Zheng D; Huang R; Wu X; Li A; Liu X
    Aging (Albany NY); 2024 Jun; 16(11):10108-10131. PubMed ID: 38870261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
    Cao J; Zhang C; Jiang GQ; Jin SJ; Wang Q; Wang AQ; Bai DS
    Bioengineered; 2021 Dec; 12(1):296-309. PubMed ID: 33380242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of methylation and transcriptome identifies a novel risk model for diagnosis, prognosis, and immune characteristics in head and neck squamous cell carcinoma.
    Zhang JW; Gao XL; Li S; Zhuang SH; Liang QW
    Mol Genet Genomics; 2024 Jul; 299(1):71. PubMed ID: 39031208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.
    Shi X; Bu X; Zhou X; Shen N; Chang Y; Yu W; Wu Y
    J Appl Genet; 2024 Sep; 65(3):519-530. PubMed ID: 38217666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Value of Methyltransferase Like 13 in Hepatocellular Carcinoma Based on Bioinformatics Analysis.
    Wen Y; Xu J; Zhou H; Liu W
    Turk J Gastroenterol; 2024 May; 35(5):385-390. PubMed ID: 39128086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and verification of a prognostic model based on coagulation and fibrinolysis-related genes in hepatocellular carcinoma.
    Fan M; Lu L; Shang H; Lu Y; Yang Y; Wang X; Lu H
    Aging (Albany NY); 2024 Apr; 16(9):7578-7595. PubMed ID: 38568089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation.
    Zhang RK; Liu JL
    BMC Med Genomics; 2021 Jun; 14(1):163. PubMed ID: 34147096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
    Wang Z; Zhang S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma.
    Zhao YJ; Wu LY; Pang JS; Liao W; Chen YJ; He Y; Yang H
    Bioengineered; 2021 Dec; 12(1):3978-3992. PubMed ID: 34288818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Fa B; Luo C; Tang Z; Yan Y; Zhang Y; Yu Z
    EBioMedicine; 2019 Jun; 44():250-260. PubMed ID: 31101593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram based on a three pyroptosis gene model and clinical parameters for predicting prognosis of hepatocellular carcinoma.
    Zhou T; Wang T; Zeng K; Qin R; Jin Y; Chen P; Ju G
    Gene; 2022 Apr; 819():146243. PubMed ID: 35122925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis.
    Liu D; Zhang P; Zhao J; Yang L; Wang W
    Biomed Res Int; 2021; 2021():5587441. PubMed ID: 34104648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of an H2AZ1-based index model: a novel prognostic tool for hepatocellular carcinoma.
    Gao J; Lu Q; Zhong J; Li Z; Pan L; Feng C; Tang S; Wang X; Tao Y; Zhou X; Wang Q
    Aging (Albany NY); 2024 Feb; 16(3):2542-2562. PubMed ID: 38305811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of methylation-driven genes for predicting the prognosis of patients with oral squamous cell carcinoma.
    Chen J; Dong Z; Li B; Nie Z; Qiu J
    Transl Cancer Res; 2024 Jun; 13(6):2892-2904. PubMed ID: 38988925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.